Orthotopic liver transplantation and what to do during follow-up: recommendations for the practitioner

被引:22
作者
Benten, Daniel [1 ]
Staufer, Katharina [1 ]
Sterneck, Martina [1 ]
机构
[1] Univ Klinikum Hamburg Eppendorf, Transplant Ctr, D-20246 Hamburg, Germany
来源
NATURE CLINICAL PRACTICE GASTROENTEROLOGY & HEPATOLOGY | 2009年 / 6卷 / 01期
关键词
cardiovascular complications; liver transplantation; long-term complications; malignancy; post-transplant care; QUALITY-OF-LIFE; HEPATIC-ARTERY THROMBOSIS; POSTTRANSPLANT LYMPHOPROLIFERATIVE DISORDER; PRIMARY SCLEROSING CHOLANGITIS; CARDIOVASCULAR RISK-FACTORS; ONSET DIABETES-MELLITUS; AUTOIMMUNE HEPATITIS; CALCINEURIN INHIBITORS; MYCOPHENOLATE-MOFETIL; BILIARY STRICTURE;
D O I
10.1038/ncpgasthep1312
中图分类号
R57 [消化系及腹部疾病];
学科分类号
100201 [内科学];
摘要
Improvements in surgical technique and the introduction of several new immunosuppressive medications mean that outcome after orthotopic liver transplantation (OLT) has improved continuously over the past 15 years. Given the increasing longevity of patients after OLT, the recognition and prevention of long-term complications after transplantation have become ever more important. With respect to graft function, physicians responsible for the everyday care of patients following transplantation should be particularly aware of the risk of late and chronic rejection episodes and of recurrence of the underlying liver disease. The major challenge of post-transplant care is, however, how best to prevent and manage the long-term adverse effects caused by the immunosuppressive medications prescribed. Screening investigations for early diagnosis of malignancy, strict control of cardiovascular risk factors, preservation of renal function, and prevention of infections are, therefore, fundamental. This Review suggests guidelines for the management of OLT recipients to improve long-term survival, overall outcome and health-related quality of life.
引用
收藏
页码:23 / 36
页数:14
相关论文
共 109 条
[1]
Hepatic artery stenosis after liver transplantation - Incidence, presentation, treatment, and long term outcome [J].
Abbasoglu, O ;
Levy, MF ;
Vodapally, MS ;
Goldstein, RM ;
Husberg, BS ;
Gonwa, TA ;
Klintmalm, GB .
TRANSPLANTATION, 1997, 63 (02) :250-255
[2]
EMPLOYMENT AFTER LIVER-TRANSPLANTATION [J].
ADAMS, PC ;
GHENT, CN ;
GRANT, DR ;
WALL, WJ .
HEPATOLOGY, 1995, 21 (01) :140-144
[3]
Inflammatory periodontal disease as a potential marker of cardiovascular risk [J].
Andrews, PA .
TRANSPLANTATION, 2005, 80 (01) :1-2
[4]
[Anonymous], AM CANC SOC GUID EAR
[5]
Who is at risk for post-transplant lymphoproliferative disorders (PTLD) after liver transplantation? [J].
Aucejo, F ;
Rofaiel, G ;
Miller, C .
JOURNAL OF HEPATOLOGY, 2006, 44 (01) :19-23
[6]
Update on immunizations in solid organ transplant recipients: What clinicians need to know [J].
Avery, R. K. ;
Michaels, M. .
AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 (01) :9-14
[7]
Presentation and early detection of post-transplant lymphoproliferative disorder after solid organ transplantation [J].
Bakker, Nicolaas A. ;
van Imhoff, Gustaaf W. ;
Verschuuren, Erik A. M. ;
van Son, Willem J. .
TRANSPLANT INTERNATIONAL, 2007, 20 (03) :207-218
[8]
Low recurrence of preexisting extrahepatic malignancies after liver transplantation [J].
Benten, Daniel ;
Sterneck, Martina ;
Panse, Jens ;
Rogiers, Xavier ;
Lohse, Ansgar W. .
LIVER TRANSPLANTATION, 2008, 14 (06) :789-798
[9]
Clinical benefits of antiviral therapy in patients with recurrent hepatitis C following liver transplantation [J].
Berenguer, M. ;
Palau, A. ;
Aguilera, V. ;
Rayon, J. -M. ;
Juan, F. S. ;
Prieto, M. .
AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 (03) :679-687
[10]
Delayed hepatic artery thrombosis in adult orthotopic liver transplantation - A 12-year experience [J].
Bhattacharjya, S ;
Gunson, BK ;
Mirza, DF ;
Mayer, DA ;
Buckels, JAC ;
McMaster, P ;
Neuberger, JM .
TRANSPLANTATION, 2001, 71 (11) :1592-1596